Showing results (251-260 of 363) with videos related to
Sort By:
Pageof 37
British Journal of Clinical Pharmacology|October 26, 2017
Parenteral bilirubin in healthy volunteers: a reintroduction in translational researchDouwe Dekker, Mirrin J Dorresteijn, Marieke E B Welzen, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2007
Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical toolsKurt J A Vanhoutte, Coby Laarakkers, Elena Marchiori, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|September 17, 2013
Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4Azza A K El-Sheikh, Rick Greupink, Heleen M Wortelboer, et al.United European Gastroenterology Journal|June 2, 2021
Discrepancy between patient- and healthcare provider-reported adverse drug reactions in inflammatory bowel disease patients on biological therapyPepijn W A Thomas, Tessa E H Römkens, Rachel L West, et al.FEBS Letters|February 23, 2016
MRP1 mediates folate transport and antifolate sensitivity in Plasmodium falciparumSanna R Rijpma, Maarten van der Velden, Albert Bilos, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and ratsJulliëtte E M van Eerd, Erik Vegt, Jack F M Wetzels, et al.Journal of Clinical Immunology|October 31, 2002
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac diseaseJan G M C Damoiseaux, Bas Bouten, Annick M L W Linders, et al.Clinical Pharmacology and Therapeutics|March 11, 2020
Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the Ex Vivo Perfused PlacentaGaby A M Eliesen, Joris van Drongelen, Hedwig van Hove, et al.European Journal of Gastroenterology & Hepatology|January 2, 2022
De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalationPepijn W A Thomas, Lisa J T Smits, Maarten Te Groen, et al.Inflammatory Bowel Diseases|February 8, 2022
Impact of Biological Therapies and Tofacitinib on Real-world Work Impairment in Inflammatory Bowel Disease Patients: A Prospective StudyPepijn W A Thomas, Nathan den Broeder, Monique Derikx, et al.Pageof 37